Less Ads, More Data, More Tools Register for FREE

Pin to quick picksME Group Regulatory News (MEGP)

Share Price Information for ME Group (MEGP)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -7.80 (-7.22%)
Bid:
100.80
Ask:
101.60
Spread: 0.80 (0.794%)
Market Cap: £377.06m
MEGP Live PriceLast checked at - London Stock Exchange

Intraday ME Group Share Chart

Form 8.3 - ME Group International plc

10 Jul 2025 15:20

RNS Number : 6070Q
BlackRock Group
10 July 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ME Group International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

09 July 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

10,869,755

2.87%

0

0.00%

(2) Cash-settled derivatives:

 

350,629

0.09%

0

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

11,220,384

2.97%

0

0.00%

*BlackRock, Inc. does not have voting authority over 632,782 shares, however investment discretion is retained.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0.5p ordinary

Transfer In of Shares

35,161

0.5p ordinary

Transfer In of Shares

512

0.5p ordinary

Transfer Out of Shares

35,161

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

10 July 2025

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPKKBBNBKDNOD
Date   Source Headline
1st Jun 202611:00 amRNSVoting Rights and Capital
1st Jun 20267:00 amRNSTrading Update
28th May 20262:12 pmRNSHolding(s) in Company
6th May 20268:00 amRNSVoting Rights and Capital
30th Apr 20265:05 pmRNSDirector/PDMR Shareholding
30th Apr 20265:03 pmRNSDirector/PDMR Shareholding
28th Apr 202612:30 pmRNSChange of duties of Executive Director
24th Apr 202612:46 pmRNSResult of AGM
21st Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20265:48 pmRNSDirector/PDMR Shareholding
13th Apr 202610:24 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNS-RNew partnership with ASDA
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:02 amRNS-RNotice of Investor Presentation
23rd Mar 20267:01 amRNSLaunch of Share Buyback Programme
23rd Mar 20267:00 amRNS2025 Annual Results
12th Mar 20261:06 pmRNSUpdate-delay in FY25 Audited Financial Statements
2nd Mar 20267:00 amRNS-RAppointment of Chief Operating Officer
26th Feb 20265:22 pmRNSHolding(s) in Company
26th Feb 202611:35 amRNSResult of GM and Share Buyback Programme
25th Feb 20267:00 amRNSDelay in FY25 Audited Financial Statements
16th Feb 20267:00 amRNS-RNotice of Investor Presentation
13th Feb 20267:00 amRNSNotice of Annual Results
10th Feb 20262:30 pmRNSNotice of GM, Share Buyback and Rule 9 waiver
2nd Feb 20265:51 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSAppointment of Deputy CEO
19th Jan 20267:00 amRNSCorporate Broker Update
14th Jan 202611:09 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSResult of secondary placing in ME Group
13th Jan 20264:37 pmRNSProposed secondary placing in ME Group
10th Dec 20253:35 pmRNSForm 8.3 ME Group International Plc Amendment
8th Dec 202510:10 amPRNForm 8.3 - ME Group International Plc
5th Dec 20255:15 pmRNSDisclosure Table
5th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) ME Group International PLC
5th Dec 202510:24 amPRNForm 8.3 - ME Group International Plc
5th Dec 20258:55 amRNSTermination of Offer Period
4th Dec 20253:20 pmRNSForm 8.3 - ME Group International plc
4th Dec 20252:55 pmRNSForm 8.3 - ME GROUP INTERNATIONAL PLC
4th Dec 20251:01 pmRNSForm 8.3 - ME Group International plc
4th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) ME Group International PLC
4th Dec 202511:49 amRNSForm 8.3 - ME Group International Plc
4th Dec 20258:44 amPRNForm 8.3 - ME Group International Plc
3rd Dec 20253:10 pmRNSForm 8.3 - ME GROUP INTERNATIONAL PLC
3rd Dec 202512:00 pmRNSForm 8.5 (EPT/RI) ME Group International PLC
3rd Dec 202511:53 amRNSForm 8.3 - ME Group International plc
2nd Dec 20253:20 pmRNSForm 8.3 - ME Group International plc
2nd Dec 20252:34 pmRNSForm 8.3 - ME GROUP INTERNATIONAL PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.